MONTREAL, March 13, 2018 /CNW Telbec/ - aqua concept GmbH announces the launch of coracon® LT EKO, an innovative and environmentally friendly family of liquid coolants based on BioAmber's bio-succinic acid. Marketed as antifreeze or brine, coracon® provides several performance advantages over existing alternatives such as: low viscosity, high pumpability, very low freezing temperatures, remarkable thermo-physical and heat exchange properties, food approval and high corrosion protection. With its positive ecological and physiological rating, coracon® LT EKO is suitable for all commercial and private systems, technical and food applications, and is particularly effective for very low temperature environments.
"Since aqua concept was founded, providing the best-in-class solutions while working to protect the environment has been a central theme in our company's culture. This innovation would not have happened without our partnership with BioAmber, that enabled us to engineer a unique product, that is both highly performing and complying with our own stringent environmental code. We foresee a successful commercialization for this product family that will bring better solutions to our customers and the market in general", explained Mr. Klukas, authorized officer of aqua concept GmbH.
"aqua concept is a great example of an innovating company that leveraged our best-in-class bio-succinic acid to design unique, eco-friendly products and solutions. It has been a pleasure joining forces and working with aqua concept. Their strong technological expertise, market experience, and dedication to developing sustainable solutions have been instrumental for the success of this joint project", said Will Raymond, Sales Manager of BioAmber.
About aqua concept:
For over 25 years aqua concept, based in Munich, Germany, has provided solutions for water treatment, engine cooling, heat transfer, corrosion protection and engineering equipment. As one of the first carbon neutral companies in the industry, environmental protection is a central responsibility. It aims to offer customers the best possible advice, system solutions to service that is tailored to customer's requirements.
For more information, visit: https://www.aqua-concept-gmbh.eu/
BioAmber (OTCPK: BIOA) is a renewable materials company. Its innovative technology platform combines biotechnology and catalysis to convert renewable feedstock into building block materials that are used in a wide variety of everyday products including plastics, paints, textiles, food additives and personal care products. For more information visit www.bio-amber.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve significant risks and uncertainties about BioAmber, including but not limited to statements with respect to BioAmber's plans to consummate its proposed underwritten offering of common stock and warrants. BioAmber may use words such as "anticipate," "believe," "could," "continue," "estimate," "expect," "intend," "may," "should," "will," "would," "plan," "projected" or the negative of such words or other similar words or phrases to identify such forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are risks relating to, among other things, whether or not BioAmber will be able to generate sufficient cash flows and obtain the additional financing necessary to continue as a going concern and to grow its business, develop its products and respond to competitive pressures, the impact of the termination of BioAmber's joint venture with Mitsui & Co. Ltd. on its ability to maintain and expand its operations at its Sarnia, Ontario facility, market and other conditions, the satisfaction of customary closing conditions related to the underwritten offering of common stock and warrants, BioAmber's business and financial condition, and the impact of general economic, industry or political conditions in the United States or internationally. For additional disclosure regarding these and other risks faced by BioAmber, see disclosures contained in BioAmber's public filings with the SEC, including the risks discussed under the heading "Item 1.A Risk Factors" in the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, and under the heading "Risk Factors" of the prospectus supplement for this offering. You should consider these factors in evaluating the forward-looking statements included in this press release and not place undue reliance on such statements. The forward-looking statements are made as of the date hereof, and BioAmber undertakes no obligation to update such statements as a result of new information.
SOURCE BioAmber Inc.
For further information: BioAmber Investor Contact: Roy McDowall, Sr. VP Business Development, 514-844-8000 Ext. 260, [email protected]